Forge Biologics Emphasizes Role in Gene Therapy Community and Manufacturing Support

According to a recent LinkedIn post from Forge Biologics, the company participated in the Gene Therapy Institute’s 2nd Annual Gene Therapy Symposium in Columbus. The post highlights active engagement with the local gene therapy community, emphasizing open discussion of challenges and shared momentum across the field.

The company’s LinkedIn post notes that Forge representative Danielle Sexton presented a poster on supporting the transition from research to scalable manufacturing. This focus on partnering with researchers at a critical development stage suggests continued positioning of Forge as a CDMO‑style enabler in gene therapy, which could support future demand, customer acquisition, and longer-term revenue visibility in the advanced therapies manufacturing market.